Biocatalysis and Biocatalyst Market Players:
- DuPont de Nemours, Inc.
- Business strategy
- Key product offerings
- Financial performance
- Risk analysis
- Recent development
- Regional presence
- SWOT Analysis
- BASF SE
- Novozymes A/S
- Lonza Group Ltd.
- Royal DSM Lockheed Martin
- Codexis, Inc.
- AB Enzymes
- Sapporo Enzyme Co., Ltd.
- Dyadic International, Inc.
- Soufflet Group
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of biocatalysis and biocatalysts is evaluated at USD 760.05 million.
The global biocatalysis and biocatalysts market size was worth over USD 719.88 million in 2025 and is poised to grow at a CAGR of around 6.2%, reaching USD 1.31 billion revenue by 2035.
The biocatalysis and biocatalyst market in North America is projected to account for the largest revenue share of 34% by 2035, driven by expanding application of biocatalysts in producing biochemicals, biofuels, and biomaterials to support waste reduction initiatives.
Key players in the market include Abbott Laboratories, Inc., Boston Scientific Corporation, Medtronic plc, Meril Life Sciences Pvt. Ltd., Inc..
